In contrast, the primary spleen tumor masses were comparable between WT and Cbl-b−/− mice in all of the experiments (Figure 7D), suggesting that Cbl-b−/− mice are not generally capable of eliminating the B16 melanoma based on their resistance to TGF-β or Tregs (7–11). The gene discussed is TGFB1; the disease is melanoma.